Biogen › Financials
Biogen financials
BIIBTen years from Biogen’s own SEC filings. Fiscal years end in December.
Income statement
| Dec 2016fiscal year | Dec 2017fiscal year | Dec 2018fiscal year | Dec 2019fiscal year | Dec 2020fiscal year | Dec 2021fiscal year | Dec 2022fiscal year | Dec 2023fiscal year | Dec 2024fiscal year | Dec 2025fiscal year | Last 12 monthsto Mar 2026 | Latest quarterMar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $11.45B | $12.27B | $13.45B | $14.38B | $13.44B | $10.98B | $10.17B | $9.84B | $9.68B | $9.89B | $9.94B | — |
| Gross profit | $9.97B | $10.64B | $11.64B | $12.42B | $11.64B | — | — | — | — | — | — | — |
| Operating income | $5.15B | $5.35B | $5.89B | $7.04B | $4.55B | $2.84B | — | — | — | — | — | — |
| Net income | $3.70B | $2.54B | $4.43B | $5.89B | $4.00B | $1.56B | $3.05B | $1.16B | $1.63B | $1.29B | $1.37B | — |
| Earnings per share, diluted | $16.93 | $11.92 | $21.58 | $31.42 | $24.80 | $10.40 | $20.87 | $7.97 | $11.18 | $8.79 | — | — |
Balance sheet
| Dec 2016fiscal year | Dec 2017fiscal year | Dec 2018fiscal year | Dec 2019fiscal year | Dec 2020fiscal year | Dec 2021fiscal year | Dec 2022fiscal year | Dec 2023fiscal year | Dec 2024fiscal year | Dec 2025fiscal year | Last 12 monthsto Mar 2026 | Latest quarterMar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | $2.33B | $1.57B | $1.22B | $2.91B | $1.33B | $2.26B | $3.42B | $1.05B | $2.38B | $3.01B | — | $3.38B |
| Total assets | $22.88B | $23.65B | $25.29B | $27.23B | $24.62B | $23.88B | $24.55B | $26.84B | $28.05B | $29.44B | — | $29.48B |
| Debt | $6.51B | $5.93B | $5.94B | $4.46B | $7.43B | $6.27B | $6.28B | $6.94B | $6.30B | $6.29B | — | $6.29B |
| Total liabilities | $10.75B | $11.05B | $12.26B | $13.90B | $13.93B | $12.92B | $11.17B | $12.05B | $11.33B | $11.18B | — | $10.83B |
| Shareholders' equity | $12.14B | $12.61B | $13.04B | $13.34B | $10.70B | $10.90B | $13.40B | $14.80B | $16.72B | $18.26B | — | $18.65B |
Cash flow
| Dec 2016fiscal year | Dec 2017fiscal year | Dec 2018fiscal year | Dec 2019fiscal year | Dec 2020fiscal year | Dec 2021fiscal year | Dec 2022fiscal year | Dec 2023fiscal year | Dec 2024fiscal year | Dec 2025fiscal year | Last 12 monthsto Mar 2026 | Latest quarterMar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $4.59B | $4.55B | $6.19B | $7.08B | $4.23B | $3.64B | $1.38B | $1.55B | $2.88B | $2.20B | $2.59B | — |
| Capital spending | $616.1M | $867.4M | $770.6M | $514.5M | $424.8M | $258.1M | $240.3M | $277.0M | $153.7M | $153.8M | $167.9M | — |
| Free cash flow | $3.97B | $3.68B | $5.42B | $6.56B | $3.81B | $3.38B | $1.14B | $1.27B | $2.72B | $2.05B | $2.42B | — |
| Buybacks | $1.00B | $1.37B | $4.35B | $5.87B | $6.68B | $1.80B | $750.0M | $0 | $0 | — | — | — |
| Returned to shareholders | $1.00B | $1.37B | $4.35B | $5.87B | $6.68B | $1.80B | $750.0M | $0 | $0 | — | — | — |
| Stock-based pay | $154.8M | $128.0M | $157.5M | $182.3M | $198.3M | $238.6M | $254.1M | $264.2M | $291.2M | $290.8M | $293.8M | — |
Where these numbers come from
Every column links to the filing it comes from on EDGAR. Last 12 months adds the latest year to date to the last 10-K and takes away the same months a year earlier. Debt is long-term debt including the part due within a year. A dash means the company did not report that line in a form we can read, never a zero. Market cap uses the latest closing price and the share count from the cover of the latest filing. How we count
Biogen financials, answered
What is Biogen's market cap?
$34.37B at $232.65 a share, with 147,753,998 shares outstanding as of Jul 27, 2026, from the cover of its latest SEC filing.
How much does Biogen earn?
Revenue of $9.94B and net income of $1.37B in the last 12 months to Mar 2026.
How much debt does Biogen have?
Biogen reported $6.29B of debt and $3.38B of cash and equivalents on its balance sheet in Mar 2026.
Does Biogen make free cash flow?
Yes. Operating cash flow minus capital spending was $2.42B in the last 12 months to Mar 2026.